日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

Region-resolved proteomic map of the human brain: functional interconnections and neurological implications

人脑区域分辨蛋白质组图谱:功能相互联系和神经学意义

Zhang, Pei-Pei; Li, Man-Sheng; Zhou, Jia; Zhu, Chu-Hong; Tang, Rui; He, Zhi-Cheng; Yao, Xiao-Hong; Ping, Yi-Fang; Xiang, Dong-Fang; Tan, Le-Yong; Wang, Yu-Jie; Wang, Shuai; Li, Si-Si; Ma, Jie; Zhu, Yun-Ping; Bian, Xiu-Wu; Leng, Ling

DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signaling

DUSP6 消融可通过增强 AP-1 信号传导来恢复因肿瘤 CD58 丢失而受损的 CAR T 细胞活性。

Ma, Xinran; Zhang, Yang; Wang, Yao; Han, Fuxin; Lu, Yuting; Tong, Chuan; Guo, Yelei; Wei, Jianshu; Zhu, Qi; Dong, Liang; Cao, Zhi; Meng, Zhenzhen; Shi, Jinhong; Wu, Zhiqiang; Han, Weidong

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

Elebsiran 和 PEG-IFNα 治疗慢性乙型肝炎感染:一项部分随机、开放标签的 II 期试验

Wong, Grace Lai-Hung; Yuen, Man-Fung; Lin, Bingliang; Douglas, Mark W; Hu, Peng; Xie, Qing; Lv, Fangfang; Tak, Won Young; Leerapun, Apinya; Kim, Dong Joon; Tangkijvanich, Pisit; Lim, Young-Suk; Dai, Chia-Yen; O'Beirne, James; Weltman, Martin; Khemnark, Suparat; Piratvisuth, Teerha; Manasirisuk, Witsarut; Chen, Xinyue; Liu, Chun-Jen; Heo, Jeong; Lee, Jooho; Niu, Junqi; Kumar, Rahul; Kumar, Rajneesh; Zhu, Chong; Cao, Ke; Tian, Alex; Chen, Xiaofei; Zhu, Qing; Margolis, David; Jia, Jidong; Hong, Zhi

Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial

高危鼻咽癌患者接受标准放化疗联合同步及辅助卡瑞利珠单抗治疗:一项多中心、随机、开放标签的3期临床试验

You, Rui; Xu, Gui-Qiong; Ding, Xi; Liang, Jin-Hui; Liu, Zhi-Gang; Zou, Xiong; Liu, You-Ping; Hu, Guang-Yuan; Liu, Yi-Min; Duan, Chong-Yang; Liu, Li-Zhi; Zhang, Wei-Jing; Liu, Qian; Li, Hui-Feng; Ouyang, Yan-Feng; Duan, Xiao-Tong; Wang, Qin; Peng, Lan; Liang, Jiong-Lin; Feng, Zheng-Kai; Qin, Zi-Han; Liu, Xiao; He, Zhi-Kun; Zhang, Bin; Long, Guo-Xian; Jiang, Yan-Hui; Lei, Feng; Huang, Pei-Yu; Hua, Yi-Jun; Chen, Ming-Yuan

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial

卡瑞利珠单抗联合 CAPOX 方案(以卡瑞利珠单抗为基础的维持治疗)与单用 CAPOX 方案作为胃癌或胃食管交界处腺癌一线治疗的疗效比较:一项随机 3 期试验

Peng, Zhi; Zhang, Yanqiao; Xu, Huiting; Yang, Yan; Yang, Mudan; Zhang, Mingjun; Cheng, Ying; Chen, Xiaobing; Pan, Yueyin; Wang, Feng; Li, Qingshan; Xu, Nong; Liu, Likun; Gu, Kangsheng; Xiao, Juxiang; Zhang, Ruixing; Zhao, Qun; Chen, Jian; Lin, Lizhu; Chen, Yigui; Deng, Yanhong; Cai, Shirong; Bai, Bin; Wang, Yiru; Shen, Lin

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial

鼻咽癌内侧咽后淋巴结区域保留放疗:一项开放标签、非劣效性、多中心、随机3期试验的五年分析

Wang, Shun-Xin; Tao, Ya-Lan; Gao, Tian-Sheng; Zhang, Ning; Zhou, Guan-Qun; Xie, Fang-Yun; Zhang, Yuan; Guo, Rui; Yang, Yi; Li, Yong-Jie; Liang, Shao-Qiang; Zeng, Yue-Can; Lin, Li; Li, Wen-Fei; Liu, Xu; Xu, Cheng; Chen, Yu-Pei; Lv, Jia-Wei; Liu, Li-Zhi; Li, Hao-Jiang; Li, Ji-Bin; Wen, Hong-Mei; Sun, Ying; Tang, Ling-Long; Liang, Xiao-Yu; Ma, Jun; Mao, Yan-Ping

Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial

新辅助TQB2102治疗局部晚期或早期人表皮生长因子受体2阳性乳腺癌的疗效和安全性:一项随机、开放标签、多中心II期试验

Li, Jun-Jie; Zhang, Wen-Juan; Zeng, Xiao-Hua; Zhang, Qing-Yuan; Chen, Li; Wu, Jiong; Liu, Guang-Yu; Wang, Zhi-Hong; Hu, Xiao-Bo; Hu, Yan-Yan; Li, Zhen-Ling; Shao, Zhi-Ming

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial

经动脉化疗栓塞联合卡瑞利珠单抗和利沃西拉尼治疗不可切除的肝细胞癌(CHANCE2005/CARES-005):一项随机II期试验

Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun